F-star Therapeutics (FSTX) Competitor Comparison
We are evaluating the key criteria listed to compare F-star Therapeutics (FSTX) against its competitors in the Biotechnology industry.
Market Capitalization
239 / 368Gross Profits
86 / 278Total Revenue
163 / 300EBITDA
115 / 337Free Cashflow
138 / 352Quick Ratio
261 / 357Earnings per Share
196 / 359Dividend yield
0 / 6Total Cash
280 / 358Performance 3 years
6 / 368Performance 5 years
176 / 368Performance 10 years
129 / 368Linearity 3 years
340 / 368Linearity 5 years
168 / 368Linearity 10 years
62 / 368Total Rank
130 / 368Dividend Rank
134 / 368Valuation Rank
58 / 368Piotroski Rank
119 / 368Muliplier Rank
112 / 368Market Capitalization - FSTX ranking 239 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.